rs727503051
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PM4PP3
The NM_004100.5(EYA4):c.902_907dupATGGCA(p.Gly302_Thr303insAsnGly) variant causes a disruptive inframe insertion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004100.5 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 10Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathy 1JInheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Gly302_Thr303insAsnGly variant in EYA4 has not been previously reported in individuals with hearing loss or in large population studies, though the abilit y of these studies to accurately detect indels may be limited. This variant caus es an in-frame insertion of two amino acid residues (Asn and Gly) between positi ons 302 and 303. The effect of this insertion on protein folding and function is not known. In summary, the clinical significance of the p.Gly302_Thr303insAsnGl y variant in uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at